Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab by Christine Sethna, Corinne Benchimol, Hilary Hotchkiss, Rachel Frank, Lulette Infante, Suzanne Vento, Howard Trachtman

Get full text

WCN24-774 PRELIMINARY FINDINGS FROM THE PHASE 2 EPPIK STUDY OF SPARSENTAN IN PEDIATRIC PATIENTS WITH SELECTED PROTEINURIC GLOMERULAR DISEASES by Radko Komers, Rosanna Coppo, Nuhira Ahmed Masthan Ahmed, Kenneth V. Lieberman, Alex Mercer, Michelle Rheault, Moin A. Saleem, Teresa Shafer, Howard Trachtman

Get full text

RESOLVE: Recurrence Posttransplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease by Eloise C. Salmon, Ashley E. Rahimi, Hailey E. Desmond, Nathaniel M. Putnam, Elena Martinelli, Elizabeth M. Hendren, Susan F. Massengill, Priya S. Verghese, Simone Sanna-Cherchi, Matthias Kretzler, Abhijit S. Naik, Howard Trachtman, Zubin J. Modi

Get full text

Elevated Exposure to Air Pollutants Accelerates Primary Glomerular Disease Progression by Jonathan P. Troost, Jennifer D’Souza, Miatta Buxton, Abhijit V. Kshirsagar, Lawrence S. Engel, Cassandra R. O’Lenick, William E. Smoyer, Jon Klein, Wenjun Ju, Sean Eddy, Margaret Helmuth, Laura H. Mariani, Matthias Kretzler, Howard Trachtman

Get full text

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study by Howard Trachtman, Jai Radhakrishnan, Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Hiddo J.L. Heerspink, Irene L. Noronha, Vlado Perkovic, Brad Rovin, Hernán Trimarchi, Muh Geot Wong, Alex Mercer, Jula Inrig, William Rote, Ed Murphy, Patricia W. Bedard, Sandra Roth, Stewart Bieler, Radko Komers

Get full text